Enanta Pharmaceuticals, Inc. ENTA
7.98 USD -0.25 (-3.04%)
Regular-session close
7.98 0.00 0.00%
After hours · Nov 19, 4:01 PM ET
7.86 Day range 8.40
7.86 52-week range 17.15
- YTD
- -49.40%
- 1 year
- -34.21%
ENTA revenue history
Revenue is income from the company’s ordinary business activities.
65,324,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-09-30 | 65,324,000 | -2,311,000 | -3.42% |
| FY 2024 | 2024-09-30 | 67,635,000 | -11,569,000 | -14.61% |
| FY 2023 | 2023-09-30 | 79,204,000 | -6,956,000 | -8.07% |
| FY 2022 | 2022-09-30 | 86,160,000 | -10,914,000 | -11.24% |
| FY 2021 | 2021-09-30 | 97,074,000 | -25,399,000 | -20.74% |
| FY 2020 | 2020-09-30 | 122,473,000 | -82,724,000 | -40.31% |
| FY 2019 | 2019-09-30 | 205,197,000 | -1,428,000 | -0.69% |
| FY 2018 | 2018-09-30 | 206,625,000 | 103,811,000 | 100.97% |
| FY 2017 | 2017-09-30 | 102,814,000 | 14,546,000 | 16.48% |
| FY 2016 | 2016-09-30 | 88,268,000 | -72,612,000 | -45.13% |
| FY 2015 | 2015-09-30 | 160,880,000 | 113,139,000 | 236.98% |
| FY 2014 | 2014-09-30 | 47,741,000 | 15,688,000 | 48.94% |
| FY 2013 | 2013-09-30 | 32,053,000 | -9,653,000 | -23.15% |
| FY 2012 | 2012-09-30 | 41,706,000 | -176,000 | -0.42% |
| FY 2011 | 2011-09-30 | 41,882,000 | 19,119,000 | 83.99% |
| FY 2010 | 2010-09-30 | 22,763,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
